Have you heard of the latest medicines to be approved by the FDA for the treatment of asthma? Nucala and Cinqair have both been approved in recent months for the treatment of severe, eosinophilic asthma. They are just the second and third biologic agents since Xolair to be approved for asthma. Learn all about Nucala and Cinqair, and speak with your doctor today to see if these unique medicines could benefit your severe asthma symptoms.
 | | | If you're having trouble viewing this email,
click here | | | | | | The Latest Medicines for the Treatment of Asthma: Nucala and Cinqair | Have you heard of the latest medicines to be approved by the FDA for the treatment of asthma? Nucala and Cinqair have both been approved in recent months for the treatment of severe, eosinophilic asthma. They are just the second and third biologic agents since Xolair to be approved for asthma. Learn all about Nucala and Cinqair, and speak with your doctor today to see if these unique medicines could benefit your severe asthma symptoms. |  | Daniel More, MD
Allergies Expert | | | | Nucala and Cinqair for the Treatment of Severe Asthma | | A number of different biologic asthma drugs are in production to address various types of asthma that may not respond to usual therapies or Xolair. Two biologic drugs were approved in late 2015 and early 2016 for the treatment of severe characterized by high amounts of blood or sputum eosinophils... | | | | | Xolair (Omalizumab) Safety and Side Effects | | Xolair (omalizumab) is an injectable medication used to treat moderate to severe allergic asthma. It can be used in people 12 years and older who still have uncontrolled asthma despite typical asthma medications, such as inhaled steroids. Injections are given in the doctor’s office every two to four weeks, depending on a person’s weight and allergic antibody (IgE) level... | | | | | Severe Asthma Attacks | | Patients are frequently referred to me with severe asthma that is difficult to control despite numerous asthma medications. Asthma medications are so effective nowadays, that when patients have uncontrolled asthma even though they are taking multiple asthma controllers, there is reason for concern. The following are the most common reasons that I find why patients have difficult-to-control asthma... | | | | | | | | | You are receiving this newsletter because you subscribed to the Allergies newsletter.
If you wish to unsubscribe, please click here | | | 1500 Broadway, 6th Floor, New York, NY, 10036 | | | | | | | | |
Nema komentara:
Objavi komentar